dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione

C146H233Cl3K2N6O27Sn — CID 159778447

About dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione

dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione (PubChem CID 159778447) has the molecular formula C146H233Cl3K2N6O27Sn and a molecular weight of 2807.75 g/mol. Its IUPAC name is dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione.

Molecular Properties

• Compound Name: dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione
• PubChem CID: 159778447
• Molecular Formula: C146H233Cl3K2N6O27Sn
• Molecular Weight: 2807.75 g/mol
• Exact Mass: 2805.44
• IUPAC Name: dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione
• SMILES: CC(C)CCCC(C)C1CCC2C3CCC4CC(C(CCC(=O)O)OO)CCC4(C)C3CCC12C.CC(C)CCCC(C)C1CCC2C3CCC4CC(C(CCC(=O)OCc5cc(N)cc(N)c5)OO)CCC4(C)C3CCC12C.CC(C)CCCC(C)C1CCC2C3CCC4CC(C(CCC(=O)OCc5cc([N+](=O)[O-])cc([N+](=O)[O-])c5)OO)CCC4(C)C3CCC12C.CC(C)CCCC(C)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C.Cl[Sn]Cl.O=C1CCC(=O)O1.O=CO[O-].O=[N+]([O-])c1cc(CCl)cc([N+](=O)[O-])c1.[H-].[K+].[K+]
• InChI: InChI=1S/C38H58N2O8.C38H62N2O4.C31H54O4.C27H48O.C7H5ClN2O4.C4H4O3.CH2O3.2ClH.2K.Sn.H/c1-24(2)7-6-8-25(3)32-11-12-33-31-10-9-28-21-27(15-17-37(28,4)34(31)16-18-38(32,33)5)35(48-46)13-14-36(41)47-23-26-19-29(39(42)43)22-30(20-26)40(44)45;1-24(2)7-6-8-25(3)32-11-12-33-31-10-9-28-21-27(15-17-37(28,4)34(31)16-18-38(32,33)5)35(44-42)13-14-36(41)43-23-26-19-29(39)22-30(40)20-26;1-20(2)7-6-8-21(3)25-11-12-26-24-10-9-23-19-22(28(35-34)13-14-29(32)33)15-17-30(23,4)27(24)16-18-31(25,26)5;1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5;8-4-5-1-6(9(11)12)3-7(2-5)10(13)14;5-3-1-2-4(6)7-3;2-1-4-3;;;;;;/h19-20,22,24-25,27-28,31-35,46H,6-18,21,23H2,1-5H3;19-20,22,24-25,27-28,31-35,42H,6-18,21,23,39-40H2,1-5H3;20-28,34H,6-19H2,1-5H3,(H,32,33);18-25,28H,6-17H2,1-5H3;1-3H,4H2;1-2H2;1,3H;2*1H;;;;/q;;;;;;;;;2*+1;+2;-1/p-3
• InChIKey: WRYHGSIQPWRJJV-UHFFFAOYSA-K
• XLogP: 30.75
• TPSA: 515.84 Ų
• H-Bond Donors: 7
• H-Bond Acceptors: 28
• Rotatable Bonds: 45
• Heavy Atoms: 185
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2807.75
LogP ≤ 5	30.75
H-Bond Donors ≤ 5	7
H-Bond Acceptors ≤ 10	28

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione?

The IUPAC name of dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione (CID 159778447) is dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione.

What is the SMILES notation for dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione?

The canonical SMILES for dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione is CC(C)CCCC(C)C1CCC2C3CCC4CC(C(CCC(=O)O)OO)CCC4(C)C3CCC12C.CC(C)CCCC(C)C1CCC2C3CCC4CC(C(CCC(=O)OCc5cc(N)cc(N)c5)OO)CCC4(C)C3CCC12C.CC(C)CCCC(C)C1CCC2C3CCC4CC(C(CCC(=O)OCc5cc([N+](=O)[O-])cc([N+](=O)[O-])c5)OO)CCC4(C)C3CCC12C.CC(C)CCCC(C)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C.Cl[Sn]Cl.O=C1CCC(=O)O1.O=CO[O-].O=[N+]([O-])c1cc(CCl)cc([N+](=O)[O-])c1.[H-].[K+].[K+].

What is the InChIKey of dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione?

The InChIKey is WRYHGSIQPWRJJV-UHFFFAOYSA-K. The full InChI is InChI=1S/C38H58N2O8.C38H62N2O4.C31H54O4.C27H48O.C7H5ClN2O4.C4H4O3.CH2O3.2ClH.2K.Sn.H/c1-24(2)7-6-8-25(3)32-11-12-33-31-10-9-28-21-27(15-17-37(28,4)34(31)16-18-38(32,33)5)35(48-46)13-14-36(41)47-23-26-19-29(39(42)43)22-30(20-26)40(44)45;1-24(2)7-6-8-25(3)32-11-12-33-31-10-9-28-21-27(15-17-37(28,4)34(31)16-18-38(32,33)5)35(44-42)13-14-36(41)43-23-26-19-29(39)22-30(40)20-26;1-20(2)7-6-8-21(3)25-11-12-26-24-10-9-23-19-22(28(35-34)13-14-29(32)33)15-17-30(23,4)27(24)16-18-31(25,26)5;1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5;8-4-5-1-6(9(11)12)3-7(2-5)10(13)14;5-3-1-2-4(6)7-3;2-1-4-3;;;;;;/h19-20,22,24-25,27-28,31-35,46H,6-18,21,23H2,1-5H3;19-20,22,24-25,27-28,31-35,42H,6-18,21,23,39-40H2,1-5H3;20-28,34H,6-19H2,1-5H3,(H,32,33);18-25,28H,6-17H2,1-5H3;1-3H,4H2;1-2H2;1,3H;2*1H;;;;/q;;;;;;;;;2*+1;+2;-1/p-3.

What are the key properties of dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione?

dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione has a molecular weight of 2807.75 g/mol, XLogP of 30.75, 45 rotatable bonds, 7 hydrogen bond donors, and 28 hydrogen bond acceptors.

Where does this data come from?

All data for dipotassium;1-(chloromethyl)-3,5-dinitrobenzene;(3,5-diaminophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;dichlorotin;10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol;4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoic acid;(3,5-dinitrophenyl)methyl 4-[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-4-hydroperoxybutanoate;hydride;oxido formate;oxolane-2,5-dione is sourced from PubChem (CID 159778447), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).